CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 87 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $793,088 | +103032.4% | 51,200 | +6.0% | 0.00% | 0.0% |
| Q1 2024 | $769 | -18.5% | 48,300 | -13.9% | 0.00% | -25.0% |
| Q4 2023 | $943 | +36.3% | 56,100 | -5.2% | 0.00% | +33.3% |
| Q3 2023 | $692 | -13.0% | 59,200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $795 | -69.4% | 59,200 | -62.3% | 0.00% | -25.0% |
| Q1 2023 | $2,601 | +187.4% | 156,900 | +222.2% | 0.00% | 0.0% |
| Q4 2022 | $905 | -99.9% | 48,700 | -22.0% | 0.00% | 0.0% |
| Q3 2022 | $800,000 | +11.4% | 62,400 | -39.1% | 0.00% | +33.3% |
| Q2 2022 | $718,000 | -17.2% | 102,500 | -2.1% | 0.00% | 0.0% |
| Q1 2022 | $867,000 | +1.0% | 104,700 | -17.4% | 0.00% | 0.0% |
| Q4 2021 | $858,000 | +1.2% | 126,800 | -20.8% | 0.00% | 0.0% |
| Q3 2021 | $848,000 | +2.8% | 160,000 | +11.5% | 0.00% | 0.0% |
| Q2 2021 | $825,000 | -8.1% | 143,500 | -26.3% | 0.00% | 0.0% |
| Q1 2021 | $898,000 | +49.7% | 194,800 | +8.3% | 0.00% | +50.0% |
| Q4 2020 | $600,000 | +20.5% | 179,800 | +7.2% | 0.00% | 0.0% |
| Q3 2020 | $498,000 | -11.7% | 167,700 | +37.3% | 0.00% | 0.0% |
| Q2 2020 | $564,000 | -1.7% | 122,100 | -18.1% | 0.00% | -33.3% |
| Q1 2020 | $574,000 | +2.7% | 149,100 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $559,000 | -56.1% | 149,100 | -37.8% | 0.00% | -33.3% |
| Q3 2019 | $1,272,000 | +96.6% | 239,800 | +42.3% | 0.00% | 0.0% |
| Q2 2019 | $647,000 | -33.4% | 168,500 | -11.6% | 0.00% | -25.0% |
| Q1 2019 | $972,000 | +166.3% | 190,600 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $365,000 | -49.3% | 190,600 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $720,000 | +3.4% | 190,600 | -14.6% | 0.00% | 0.0% |
| Q2 2018 | $696,000 | +30.6% | 223,100 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $533,000 | -16.3% | 223,100 | +36.9% | 0.00% | -33.3% |
| Q4 2017 | $637,000 | +2175.0% | 163,000 | +576.3% | 0.00% | – |
| Q1 2016 | $28,000 | -52.5% | 24,100 | 0.0% | 0.00% | – |
| Q4 2015 | $59,000 | -18.1% | 24,100 | 0.0% | 0.00% | – |
| Q3 2015 | $72,000 | -27.3% | 24,100 | 0.0% | 0.00% | – |
| Q2 2015 | $99,000 | – | 24,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |